Clinical Trials Browser

Interventional × Hematologic Diseases × Injections × Clear all

NCT05755854 2023-09-22

Allogeneic γ9δ2 T Cells Treatment of Recurrent Hematologic Tumors

Phase 1 Unknown

Hematologic Diseases